Replay available

Neuronetics, Inc. (STIM) Q3 2025 Earnings Call

Neuronetics, Inc. (NASDAQ: STIM) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.

Tue, November 4, 2025 at 8:30 AMendedReplay
Neuronetics, Inc. (STIM) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Mark Klossner

Investor Relations

Keith Sullivan

President and Chief Executive Officer

Steve Fanstiel

Chief Financial Officer

William Lobanich

Analyst, Canaccord Genuity

Kyle Winborn

Analyst, Piper Sandler

Daniel Stouter

Analyst, Citizens

Replay transcript excerpt

day and thank you for standing by. Welcome to the Neuronetics third quarter 2025 earnings conference call. At this time all participants are in a listen only mode. After the speaker's presentation there will be a question and answer session. To ask a question during the session you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question please press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Mark Klossner, Investor Relations. Please go ahead. Good morning, and thank you for joining us for the Neuronetics third quarter 2025 conference call. Joining me on today's call are Neuronetics President and Chief Executive Officer Keith Sullivan and Steve Fanstiel, Neuronetics Chief Financial Officer. Before I begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements covered under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to our business, strategy, financial and revenue guidance, the Green Book integration, and other operational issues and metrics. Actual results can differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. For a discussion of risks and uncertainties associated with the Neuronetics business, I encourage you to review the company's filings with the Securities and Exchange Commission, including the company's quarterly report on Form 10-Q, which was filed pre-market today. The company disclaims any obligation to...

More from Neuronetics, Inc.